tm logo

Monitor this mark

View On USPTO

RUPTMEZO
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 09 Jul 2024

Last Applicant/ Owned by

Glycomimetics, Inc.

9708 Medical Center Drive

Rockville

MD

20850

Serial Number

98206835 filed on 02th Oct 2023

Registration Number

N/A

Correspondent Address

Naresh Kilaru

NARESH KILARU FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP

WASHINGTON, DC 20001

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RUPTMEZO

pharmaceuticals for the treatment of acute myeloid leukemia and other cancers; anti-cancer preparations

Classification Information

Class [005]
Pharmaceutical Products

pharmaceuticals for the treatment of acute myeloid leukemia and other cancers; anti-cancer preparations

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98206835

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 12331.0119

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Status DateAction Taken
09th Jul 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14th May 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14th May 2024PUBLISHED FOR OPPOSITION
24th Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09th Apr 2024APPROVED FOR PUB - PRINCIPAL REGISTER
09th Apr 2024ASSIGNED TO EXAMINER
12th Oct 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05th Oct 2023NEW APPLICATION ENTERED